This week we have the second part of our two-art interview with Dr. Janice Smiell, CMO at Alliqua BioMedical, Inc. Dr. Smiell, and we delve a little deeper into the specifics of this new technology to heal chronic wounds using placental biomaterials. Steve Freed: With all the testing that is …

The drug reps for DPP-4 inhibitors, GLP-1 agonists, and various insulins have been having a field day talking to prescribers about the possible cardiovascular effects of SGLT-2 inhibitors. This along with the relatively small risk of UTI’s has possibly caused some of our readers to shy away from the whole …

In this week’s Homerun Slides, we continue our short series on introducing SGLT-2 inhibitor therapy to your patients. Topics this week include: Logic for SGLT-2 Inhibition, But Won’t Sugar Hurt My Kidneys, and CV Risk factor Changes with SGLT-2 Inhibitors…